Status:
RECRUITING
Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers
Lead Sponsor:
Oslo University Hospital
Conditions:
Locally Advanced Pelvic Cancer That Require Pelvic Exenteration
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Radium Hospital Oslo University Hospital Estimated date of first patient enrolled: 3rd quarter 2021 Anticipated recruitment period: 4 years Estimated date of last patient completed: 4th quarter 20...
Detailed Description
Pelvic exenteration for locally advanced rectal cancer (LARC) and locally advanced sigmoid cancer LARC includes tumours threatening the mesorectal fascia or invading adjacent organs and structures (9)...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years)
- locally advanced pelvic cancer that require pelvic exenteration
- eligible for robot- assisted minimally invasive surgery by the respective multidisciplinary teams, may be included in the study.
Exclusion
- Any reason why the patient in the investigator's opinion is not suited for inclusion.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05186493
Start Date
November 1 2021
End Date
December 1 2030
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital The Radium Hospital
Oslo, Norway